Tara Taraneh Farah, MD
Family Practice · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
Offices
3 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Research they published
1 paper · cited 209 times
Published as Tara Farah at Medical University of Lublin.
Research identity is not a guarantee of current clinical practice. Same name is not the same person — if this looks like someone else, tell us.
| 2015 | Psychiatric aspects of brain tumors: A review | World Journal of Psychiatry |
Topics: Glioma Diagnosis and Treatment · Pituitary Gland Disorders and Treatments · Brain Metastases and Treatment
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Farah’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A169405 · Current
Licensed to practise in California · since 2020 · expires 2028-07-31 · Medical University of Lublin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$57,955
Medicare paid this office $57,955 for 256 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 173 | $22,341 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 79 | $12,093 | $153 |
| Return visit (30+ min) | 56 | $6,875 | $103 |
| Short return visit | 46 | $2,617 | $46 |
| New patient visit (45+ min) | 13 | $1,529 | $118 |
See all 10 services
| Short return visit (20+ min) | 173 | $22,341 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 79 | $12,093 | $153 |
| Return visit (30+ min) | 56 | $6,875 | $103 |
| Short return visit | 46 | $2,617 | $46 |
| New patient visit (45+ min) | 13 | $1,529 | $118 |
| Long return visit (40+ min) | 11 | $1,439 | $131 |
| Influenza vaccine split virus, preservative free | 14 | $1,051 | $75 |
| New patient visit (30+ min) | 12 | $793 | $66 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 31 | $532 | $15 |
| Administration of influenza virus vaccine | 13 | $497 | $38 |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
256 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 10% · Women 65% · Also on Medicaid 19% · Health risk score 1.20. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 71% · Chronic kidney disease 27% · Coronary heart disease 23% · Diabetes 22% · Depression 20% · Cancer 17% · Heart failure 16% · COPD 13% · Atrial fibrillation 13% · Dementia 10% · Stroke 8%.
The office billed $208,457, Medicare allowed $77,031 and paid $57,955; for 792 services of 28 kinds; $6,607 of it was for drugs given in the office and $51,348 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 256 | 792 | 74 | 1.20 | $208,457 | $57,955 |
| 2023 | 306 | 685 | 73 | 1.12 | $212,098 | $56,673 |
| 2022 | 305 | 444 | 76 | 1.13 | $119,654 | $33,682 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 180 | $18,993 | $75 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 20 | $5,638 | $282 |
| New patient visit (45+ min) | 37 | $5,271 | $142 |
| Return visit (30+ min) | 39 | $5,041 | $117 |
| Long return visit (40+ min) | 18 | $3,386 | $169 |
| Short return visit | 55 | $2,926 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,906 | $153 |
| New patient visit (30+ min) | 34 | $2,877 | $85 |
| Influenza vaccine split virus, preservative free | 24 | $1,720 | $72 |
| Administration of influenza virus vaccine | 27 | $980 | $36 |
| Administration of pneumococcal vaccine | 20 | $726 | $36 |
2022: 4 services
| Short return visit (20+ min) | 185 | $14,167 | $69 |
| Return visit (30+ min) | 69 | $7,337 | $93 |
| Long return visit (40+ min) | 41 | $6,153 | $128 |
| Short return visit | 50 | $1,838 | $35 |
Medicaid work
$2,275 in 2022
Medicaid paid $2,275 for 41 billed services this clinician did in 2022, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 41 | $2,275 |
| 2022 | 41 | 1 | 25 | $2,275 |
| 2021 | 13 | 1 | 13 | $150 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 13 | $150 |
Drugs they prescribed that Part D paid
$87,173
Pharmacies billed $87,173 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (32 of 1,481) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,345 generic and fewer than 11 brand-name prescriptions · $87,173 in drug cost · 48 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 21 | $13,907 | $662 |
| Ozempic | 14 | $12,650 | $904 |
| Duloxetine | 35 | $1,268 | $36 |
| Olmesartan Medoxomil | 46 | $1,106 | $24 |
| Ipratropium | 32 | $1,000 | $31 |
See all 32 drugs
| Trelegy Ellipta | 21 | $13,907 | $662 |
| Ozempic | 14 | $12,650 | $904 |
| Duloxetine | 35 | $1,268 | $36 |
| Olmesartan Medoxomil | 46 | $1,106 | $24 |
| Ipratropium | 32 | $1,000 | $31 |
| Atorvastatin | 101 | $939 | $9 |
| Gabapentin | 18 | $820 | $46 |
| Levothyroxine | 65 | $807 | $12 |
| Amlodipine Besylate | 66 | $610 | $9 |
| Rosuvastatin | 34 | $596 | $18 |
| Losartan | 53 | $523 | $10 |
| Fluticasone Propionate | 37 | $455 | $12 |
| Omeprazole | 22 | $445 | $20 |
| Sertraline | 19 | $333 | $18 |
| Albuterol Sulfate Hfa | 15 | $322 | $21 |
| Tamsulosin | 25 | $322 | $13 |
| Pantoprazole | 30 | $276 | $9 |
| Bupropion Xl | 13 | $221 | $17 |
| Lisinopril | 33 | $221 | $7 |
| Simvastatin | 17 | $221 | $13 |
| Cyclobenzaprine | 15 | $196 | $13 |
| Metformin Hcl Er | 22 | $195 | $9 |
| Trazodone | 13 | $162 | $12 |
| Nitrofurantoin Mono-Macro | 12 | $120 | $10 |
| Fluoxetine | 11 | $117 | $11 |
| Hydralazine | 17 | $106 | $6 |
| Metoprolol | 24 | $94 | $4 |
| Lorazepam | 25 | $92 | $4 |
| Metformin | 18 | $88 | $5 |
| Hydrochlorothiazide | 19 | $68 | $4 |
| Amoxicillin | 12 | $59 | $5 |
| Alprazolam | 18 | $53 | $3 |
Year by year
| 2024 | 1,481 | 255 | 2% (32) | None | $87,173 |
| 2023 | 1,399 | 466 | 3% (35) | 8% | $98,629 |
| 2022 | 2,614 | 581 | 3% (73) | 10% | $121,975 |
| 2021 | 3,084 | 332 | 6% (195) | 11% | $127,794 |
| 2020 | 383 | 113 | 7% (26) | None | $29,162 |
| 2019 | 166 | 51 | None | None | $8,817 |
| 2018 | 180 | 51 | None | 8% | $5,552 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Atorvastatin | 100 | $1,595 | $16 |
| Ipratropium | 48 | $1,262 | $26 |
| Levothyroxine | 54 | $1,002 | $19 |
| Duloxetine | 16 | $847 | $53 |
| Losartan | 45 | $842 | $19 |
| Albuterol Sulfate Hfa | 21 | $738 | $35 |
| Dicyclomine | 15 | $714 | $48 |
| Amlodipine Besylate | 58 | $664 | $11 |
| Olmesartan Medoxomil | 13 | $648 | $50 |
| Fluticasone Propionate | 25 | $644 | $26 |
| Metformin Hcl Er | 15 | $556 | $37 |
| Rosuvastatin | 37 | $546 | $15 |
| Metoprolol | 18 | $481 | $27 |
| Escitalopram | 21 | $463 | $22 |
| Metformin | 31 | $429 | $14 |
| Lisinopril | 40 | $426 | $11 |
| Fluoxetine | 17 | $367 | $22 |
| Gabapentin | 19 | $366 | $19 |
| Pantoprazole | 19 | $366 | $19 |
| Nystatin | 15 | $323 | $22 |
| Omeprazole | 15 | $295 | $20 |
| Mirtazapine | 11 | $281 | $26 |
| Tamsulosin | 20 | $253 | $13 |
| Lorazepam | 17 | $190 | $11 |
| Trazodone | 18 | $167 | $9 |
| Carvedilol | 13 | $153 | $12 |
| Paxlovid (Eua) | 15 | $153 | $10 |
| Hydrochlorothiazide | 18 | $146 | $8 |
| Azelastine | 13 | $123 | $9 |
| Acetaminophen-Codeine | 11 | $122 | $11 |
| Metoprolol | 19 | $120 | $6 |
| Alendronate | 11 | $116 | $11 |
| Cyclobenzaprine | 15 | $111 | $7 |
| Simvastatin | 11 | $108 | $10 |
| Alprazolam | 14 | $105 | $8 |
| Triamcinolone Acetonide | 14 | $83 | $6 |
2022: 64 drugs
| Xarelto | 13 | $10,117 | $778 |
| Spiriva Respimat | 11 | $5,577 | $507 |
| Levothyroxine | 129 | $2,767 | $21 |
| Atorvastatin | 171 | $2,309 | $14 |
| Alvesco | 14 | $1,846 | $132 |
| Gabapentin | 58 | $1,825 | $31 |
| Wixela Inhub | 12 | $1,719 | $143 |
| Losartan | 93 | $1,208 | $13 |
| Dicyclomine | 31 | $1,199 | $39 |
| Ipratropium | 28 | $1,098 | $39 |
| Diclofenac | 26 | $1,082 | $42 |
| Albuterol Sulfate Hfa | 52 | $1,076 | $21 |
| Amlodipine Besylate | 96 | $1,024 | $11 |
| Duloxetine | 43 | $965 | $22 |
| Fluticasone Propionate | 52 | $879 | $17 |
| Hydrocodone-Acetaminophen | 46 | $766 | $17 |
| Losartan-Hydrochlorothiazide | 30 | $700 | $23 |
| Humulin N | 12 | $686 | $57 |
| Lisinopril | 63 | $640 | $10 |
| Atenolol | 42 | $599 | $14 |
| Trazodone | 40 | $587 | $15 |
| Pantoprazole | 34 | $586 | $17 |
| Metoprolol | 30 | $584 | $19 |
| Metoprolol | 54 | $526 | $10 |
| Rosuvastatin | 36 | $524 | $15 |
| Propranolol | 12 | $522 | $44 |
| Mirtazapine | 24 | $520 | $22 |
| Tamsulosin | 31 | $504 | $16 |
| Simvastatin | 46 | $498 | $11 |
| Omeprazole | 29 | $471 | $16 |
| Terazosin | 12 | $466 | $39 |
| Ondansetron Odt | 27 | $463 | $17 |
| Sertraline | 21 | $427 | $20 |
| Hydrochlorothiazide | 46 | $414 | $9 |
| Lisinopril-Hydrochlorothiazide | 37 | $403 | $11 |
| Venlafaxine Hcl Er | 14 | $393 | $28 |
| Alendronate | 28 | $348 | $12 |
| Pregabalin | 11 | $330 | $30 |
| Triamcinolone Acetonide | 20 | $291 | $15 |
| Carvedilol | 23 | $266 | $12 |
| Metformin Hcl Er | 30 | $266 | $9 |
| Metformin | 25 | $264 | $11 |
| Bupropion Xl | 13 | $261 | $20 |
| Furosemide | 24 | $251 | $10 |
| Nitrofurantoin Mono-Macro | 17 | $239 | $14 |
| Fluoxetine | 16 | $206 | $13 |
| Potassium Chloride | 12 | $206 | $17 |
| Lovastatin | 16 | $200 | $12 |
| Famotidine | 14 | $196 | $14 |
| Warfarin | 12 | $193 | $16 |
| Donepezil | 14 | $181 | $13 |
| Escitalopram | 12 | $180 | $15 |
| Glipizide | 15 | $179 | $12 |
| Ibuprofen | 12 | $176 | $15 |
| Paxlovid (Eua) | 16 | $157 | $10 |
| Buspirone | 15 | $149 | $10 |
| Hydroxyzine | 19 | $146 | $8 |
| Tramadol | 13 | $139 | $11 |
| Amoxicillin | 18 | $112 | $6 |
| Quetiapine | 11 | $88 | $8 |
| Lorazepam | 11 | $85 | $8 |
| Alprazolam | 13 | $80 | $6 |
| Meloxicam | 11 | $68 | $6 |
| Prednisone | 12 | $47 | $4 |
2021: 75 drugs
| Pradaxa | 15 | $9,604 | $640 |
| Spiriva Respimat | 19 | $9,213 | $485 |
| Wixela Inhub | 40 | $4,292 | $107 |
| Levothyroxine | 105 | $2,357 | $22 |
| Alvesco | 15 | $2,249 | $150 |
| Hydrocodone-Acetaminophen | 111 | $2,215 | $20 |
| Atorvastatin | 138 | $1,649 | $12 |
| Duloxetine | 48 | $1,552 | $32 |
| Gabapentin | 71 | $1,373 | $19 |
| Albuterol Sulfate Hfa | 68 | $1,359 | $20 |
| Diclofenac | 44 | $1,260 | $29 |
| Amlodipine Besylate | 90 | $1,029 | $11 |
| Fluticasone Propionate | 69 | $926 | $13 |
| Humulin N | 14 | $926 | $66 |
| Losartan | 76 | $913 | $12 |
| Atenolol | 69 | $879 | $13 |
| Lisinopril | 70 | $826 | $12 |
| Tamsulosin | 55 | $818 | $15 |
| Clobetasol Propionate | 20 | $709 | $35 |
| Metoprolol | 73 | $699 | $10 |
| Pantoprazole | 54 | $656 | $12 |
| Trazodone | 51 | $641 | $13 |
| Estradiol | 11 | $592 | $54 |
| Tramadol | 48 | $571 | $12 |
| Venlafaxine Hcl Er | 12 | $543 | $45 |
| Sertraline | 24 | $541 | $23 |
| Terazosin | 16 | $516 | $32 |
| Propranolol | 25 | $512 | $20 |
| Furosemide | 45 | $496 | $11 |
| Rosuvastatin | 38 | $488 | $13 |
| Simvastatin | 42 | $480 | $11 |
| Triamcinolone Acetonide | 29 | $473 | $16 |
| Omeprazole | 24 | $462 | $19 |
| Oxycodone-Acetaminophen | 19 | $436 | $23 |
| Famotidine | 35 | $436 | $12 |
| Hydrochlorothiazide | 43 | $402 | $9 |
| Tizanidine | 27 | $393 | $15 |
| Metoprolol | 22 | $387 | $18 |
| Losartan-Hydrochlorothiazide | 14 | $354 | $25 |
| Dicyclomine | 19 | $331 | $17 |
| Ondansetron Odt | 22 | $327 | $15 |
| Metformin | 29 | $321 | $11 |
| Ibuprofen | 25 | $321 | $13 |
| Prazosin | 11 | $310 | $28 |
| Ropinirole | 20 | $306 | $15 |
| Fluoxetine | 22 | $304 | $14 |
| Methocarbamol | 16 | $292 | $18 |
| Pregabalin | 13 | $285 | $22 |
| Alendronate | 27 | $281 | $10 |
| Warfarin | 20 | $272 | $14 |
| Nitrofurantoin Mono-Macro | 17 | $271 | $16 |
| Metformin Hcl Er | 32 | $264 | $8 |
| Glipizide | 23 | $260 | $11 |
| Lisinopril-Hydrochlorothiazide | 25 | $250 | $10 |
| Lactulose | 12 | $225 | $19 |
| Escitalopram | 20 | $224 | $11 |
| Mirtazapine | 11 | $213 | $19 |
| Nabumetone | 11 | $210 | $19 |
| Cephalexin | 18 | $209 | $12 |
| Doxycycline Monohydrate | 12 | $208 | $17 |
| Tadalafil | 15 | $205 | $14 |
| Lovastatin | 16 | $199 | $12 |
| Alprazolam | 30 | $198 | $7 |
| Buspirone | 26 | $187 | $7 |
| Citalopram Hbr | 13 | $182 | $14 |
| Hydroxyzine | 25 | $179 | $7 |
| Lorazepam | 26 | $172 | $7 |
| Diltiazem | 11 | $166 | $15 |
| Amoxicillin | 19 | $146 | $8 |
| Montelukast | 14 | $143 | $10 |
| Prednisone | 15 | $112 | $7 |
| Diazepam | 16 | $108 | $7 |
| Meloxicam | 12 | $108 | $9 |
| Ondansetron | 12 | $92 | $8 |
| Clonazepam | 11 | $86 | $8 |
2020: 8 drugs
| Atorvastatin | 33 | $231 | $7 |
| Labetalol | 11 | $114 | $10 |
| Amlodipine Besylate | 19 | $108 | $6 |
| Pantoprazole | 18 | $93 | $5 |
| Tramadol | 12 | $82 | $7 |
| Metformin Hcl Er | 12 | $58 | $5 |
| Famotidine | 11 | $57 | $5 |
| Lisinopril | 11 | $55 | $5 |
2019: 2 drugs
| Atorvastatin | 17 | $119 | $7 |
| Amlodipine Besylate | 14 | $30 | $2 |
2018: 4 drugs
| Phenytoin | 11 | $1,261 | $115 |
| Potassium Chloride | 21 | $239 | $11 |
| Propranolol | 25 | $180 | $7 |
| Furosemide | 23 | $62 | $3 |
Professional record
- NPI
- 1851829642
- Licence
- CA A169405, ND RL14595California A169405: Current · expires 2028-07-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 5800 Hollis St, Emeryville, CA, 94608
- NPI first listed
- 2017-05-24
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 725 Hamline St, Grand Forks, ND, 58203 · 300 Pasteur Dr, Palo Alto, CA, 94304
This office lists an electronic records connection.